BioMarin to Attend Three Upcoming Investor Conferences

- Credit Suisse 25th Annual Healthcare Conference on November 7 in Scottsdale, Arizona

- Jefferies 2016 London Healthcare Conference on November 16 in London

- Citi 2016 Global Healthcare Conference on December 8 in New York City

SAN RAFAEL, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Credit Suisse 25th Annual Healthcare Conference on November 7, 2016 at 10:00am MT/12:00pm ET, in Scottsdale, Arizona. Management will also participate in the Jefferies 2016 London Healthcare Conference on November 16, 2016, in London and the Citi 2016 Global Healthcare Conference on December 8, 2016 at 8:45am ET, in New York City.  Webcasts will be available for the Credit Suisse and Citi conferences. To access the live webcasts, please visit the investor section of the BioMarin website, www.BMRN.com. A replay will also be archived on the site for at least one week following the event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558

Media
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451

Source: BioMarin Pharmaceutical Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $62 at RBC Capital
• Narmi Launches AI Decision Assist to Streamline Customer Account Opening for Community Banks and Credit Unions
• Sycomp's Allen Shahdadi Honored as a 2026 CRN Inclusive Channel Leader